2.
Variable | cases (n) | Univariate | Multivariate | |||||
P | HR | 95%CI | P | HR | 95%CI | |||
Gender | 0.131 | |||||||
Male | 317 | |||||||
Female | 59 | 0.750 | 0.517~1.089 | |||||
Age (year) | 0.696 | |||||||
≤72 | 328 | |||||||
≥73 | 48 | 1.076 | 0.745~1.553 | |||||
Primary site | 0.004 | 0.009 | ||||||
Upper third of esophagus | 5 | |||||||
Middle third of esophagus | 33 | 1.034 | 0.311~3.435 | 0.997 | 0.300~3.310 | |||
Lower third of esophagus | 309 | 1.034 | 0.311~3.435 | 0.997 | 0.300~3.310 | |||
Abdominal esophagus | 4 | 4.199 | 0.932~18.924 | 3.182 | 0.705~14.361 | |||
Overlapping lesion of esophagus | 15 | 1.153 | 0.321~4.142 | 0.864 | 0.240~3.118 | |||
Thoracic esophagus | 10 | 0.484 | 0.115~2.033 | 0.445 | 0.106~1.871 | |||
Grade | 0.410 | |||||||
Ⅰ | 13 | |||||||
Ⅱ | 141 | 0.757 | 0.394~1.455 | |||||
Ⅲ | 216 | 0.821 | 0.432~1.560 | |||||
Ⅳ | 6 | 1.531 | 0.522~4.489 | |||||
Pathological type | 0.992 | |||||||
Squamous cell carcinoma | 60 | |||||||
Adenocarcinoma | 285 | 0.985 | 0.700~1.386 | |||||
Others | 31 | 0.968 | 0.565~1.656 | |||||
T stage | 0.089 | |||||||
T1 | 20 | |||||||
T2 | 40 | 0.788 | 0.384~1.619 | |||||
T3 | 284 | 1.129 | 0.614~2.074 | |||||
T4 | 32 | 1.649 | 0.807~3.372 | |||||
M stage | 0.015 | 0.012 | 1.827 | 1.140~2.929 | ||||
M0 | 352 | |||||||
M1 | 24 | 1.792 | 1.121~2.865 | |||||
Tumor size (mm) | 0.230 | |||||||
≤72 | 293 | |||||||
≥73 | 83 | 1.197 | 0.892~1.607 | |||||
Race | 0.391 | |||||||
White | 332 | |||||||
Black | 23 | 1.471 | 0.930~2.327 | |||||
Asian | 17 | 0.938 | 0.481~1.831 | |||||
Others | 4 | 1.417 | 0.352~5.708 | |||||
LNR | 0.000 | 0.000 | 1.827 | 1.140~2.929 | ||||
< 0.16 | 188 | |||||||
≥0.16 | 188 | 1.917 | 1.917 | |||||
Number of lymph nodes tested | 0.216 | |||||||
≤8 | 159 | 0.854 | 0.665~1.097 | |||||
≥9 | 217 |